Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · IEX Real-Time Price · USD
9.36
+0.14 (1.52%)
Jul 22, 2024, 10:10 AM EDT - Market open
Benitec Biopharma Employees
Benitec Biopharma had 18 employees as of June 30, 2023. The number of employees did not change compared to the previous year.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$389
Profits / Employee
-$1,205,111
Market Cap
88.70M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sangamo Therapeutics | 405 |
Alpha Teknova | 211 |
CASI Pharmaceuticals | 176 |
Hyperfine | 131 |
AlloVir | 112 |
HilleVax | 90 |
Verastem | 73 |
AN2 Therapeutics | 41 |
BNTC News
- 7 days ago - Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study - GlobeNewsWire
- 2 months ago - Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update - GlobeNewsWire
- 3 months ago - Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study - GlobeNewsWire
- 3 months ago - Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million - GlobeNewsWire
- 5 months ago - Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update - GlobeNewsWire
- 8 months ago - Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy - GlobeNewsWire
- 8 months ago - Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 9 months ago - Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update - GlobeNewsWire